About
Arcellx Inc (NASDAQ:ACLX) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 17 2026
Gilead Receives All Required Regulatory Approvals for the Acquisition of Arcellx and Extends Tender Offer
Apr 1 2026
Gilead Extends Tender Offer to Acquire Arcellx
Feb 23 2026
Gilead Sciences to Acquire Arcellx to Maximize Long-term Potential of Anito-cel
Feb 4 2026
Arcellx Announces Late-Breaking Presentation at TANDEM Demonstrating Unique, High Target-Specificity of anito-cel’s D-Domain Binder
Jan 21 2026
Arcellx to Advance the Conversation on Its Platform and the Importance of Early CAR T Access for Patients with Multiple Myeloma During the 2026 Tandem Meetings
Financials
Revenue
$22.29 M
Market Cap
$6.71 B
EPS
-4.08
Translate